Clinical and biological significance of hepsin overexpression in breast cancer
- PMID: 21383634
- DOI: 10.2310/JIM.0b013e31821451a1
Clinical and biological significance of hepsin overexpression in breast cancer
Abstract
Objective: Although many studies have documented the tumor-promoting role of hepsin in several types of malignancies, little is known about its clinical and biological significance in breast cancer.
Materials and methods: Hepsin expression was examined in 4 pairs of fresh breast tumor samples and corresponding nontumor breast tissues by Western blotting. Immunohistochemistry for hepsin was performed on an additional cohort of 215 archival breast cancer samples. The clinical significance of hepsin expression was analyzed. Knockdown of hepsin expression was performed in 2 breast cancer cell lines, MDA-MB-231 and HER18, with a high abundance of endogenous hepsin, and the effects of hepsin silencing on cell invasion and proliferation were evaluated.
Results: Hepsin was aberrantly overexpressed in breast cancer tissues relative to adjacent nontumor tissues. Its overexpression was significantly associated with tumor stage (P = 0.037), lymph node metastasis (P = 0.010), estrogen receptor positivity (P = 0.019), and progesterone receptor positivity (P < 0.0001) in patients with breast cancer. Down-regulation of hepsin expression by small interfering RNA (siRNA) significantly reduced cell proliferation and invasion in both the MDA-MB-231 and HER18 cells compared to nonspecific control small interference RNA.
Conclusion: Our data demonstrate that hepsin expression is frequently up-regulated in breast cancer tissues, which is associated with tumor growth and progression. Thus, inhibition of hepsin expression might be of therapeutic significance.
Similar articles
-
Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.Anticancer Res. 2008 Jan-Feb;28(1A):159-64. Anticancer Res. 2008. PMID: 18383840
-
Cathepsin D enhances breast cancer invasion and metastasis through promoting hepsin ubiquitin-proteasome degradation.Cancer Lett. 2018 Dec 1;438:105-115. doi: 10.1016/j.canlet.2018.09.021. Epub 2018 Sep 15. Cancer Lett. 2018. PMID: 30227221
-
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.Cancer Res. 2006 Apr 1;66(7):3611-9. doi: 10.1158/0008-5472.CAN-05-2983. Cancer Res. 2006. PMID: 16585186
-
Hepsin and prostate cancer.Front Biosci. 2007 Sep 1;12:5052-9. doi: 10.2741/2447. Front Biosci. 2007. PMID: 17569629 Review.
-
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer.Biomolecules. 2022 Jan 25;12(2):203. doi: 10.3390/biom12020203. Biomolecules. 2022. PMID: 35204704 Free PMC article. Review.
Cited by
-
Hepsin promotes breast tumor growth signaling via the TGFβ-EGFR axis.Mol Oncol. 2024 Mar;18(3):547-561. doi: 10.1002/1878-0261.13545. Epub 2023 Nov 13. Mol Oncol. 2024. PMID: 37872868 Free PMC article.
-
Cell surface-anchored serine proteases in cancer progression and metastasis.Cancer Metastasis Rev. 2019 Sep;38(3):357-387. doi: 10.1007/s10555-019-09811-7. Cancer Metastasis Rev. 2019. PMID: 31529338 Free PMC article. Review.
-
The role of the cell-cell interactions in cancer progression.J Cell Mol Med. 2015 Feb;19(2):283-96. doi: 10.1111/jcmm.12408. Epub 2015 Jan 19. J Cell Mol Med. 2015. PMID: 25598217 Free PMC article. Review.
-
Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity.Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):E388-97. doi: 10.1073/pnas.1120421109. Epub 2012 Jan 20. Proc Natl Acad Sci U S A. 2012. PMID: 22308451 Free PMC article.
-
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.BMC Cancer. 2015 May 27;15:431. doi: 10.1186/s12885-015-1440-5. BMC Cancer. 2015. PMID: 26014348 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous